In today’s Washington Post, columnist Bob Samuelson writes:
Then there’s the Independent Payment Advisory Board (IPAB), a body of 15 experts charged with limiting Medicare spending if it passes certain targets. But the law handcuffs IPAB. It can’t increase patient cost‐sharing, restrict benefits, modify eligibility requirements or — in any one year — cut spending by more than 1.5 percent, reports the Kaiser Family Foundation.
All four of those assertions about supposed limitations on IPAB’s powers are false, as Diane Cohen and I explain here.